These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2658377)

  • 1. Role of milrinone in the management of congestive heart failure.
    Hilleman DE; Forbes WP
    DICP; 1989 May; 23(5):357-62. PubMed ID: 2658377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Milrinone. A preliminary review of its pharmacological properties and therapeutic use.
    Young RA; Ward A
    Drugs; 1988 Aug; 36(2):158-92. PubMed ID: 3053125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Milrinone, a new agent for the treatment of congestive heart failure.
    Hasegawa GR
    Clin Pharm; 1986 Mar; 5(3):201-5. PubMed ID: 3514085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study.
    Anderson JL; Baim DS; Fein SA; Goldstein RA; LeJemtel TH; Likoff MJ
    J Am Coll Cardiol; 1987 Apr; 9(4):711-22. PubMed ID: 3549837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preload-dependent hemodynamic effects of milrinone in moderate heart failure.
    Remme WJ; van Hoogenhuyze DC; Kruijssen HA; Pieper PG; Bruggeling WA
    Cardiology; 1992; 80(2):132-42. PubMed ID: 1611632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure.
    Baim DS; McDowell AV; Cherniles J; Monrad ES; Parker JA; Edelson J; Braunwald E; Grossman W
    N Engl J Med; 1983 Sep; 309(13):748-56. PubMed ID: 6888453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term intravenous milrinone for severe congestive heart failure: the good, bad, and not so good.
    Varriale P; Ramaprasad S
    Pharmacotherapy; 1997; 17(2):371-4. PubMed ID: 9085331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Milrinone-Dobutamine Study Group.
    Karlsberg RP; DeWood MA; DeMaria AN; Berk MR; Lasher KP
    Clin Cardiol; 1996 Jan; 19(1):21-30. PubMed ID: 8903534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous milrinone following cardiac surgery: I. Effects of bolus infusion followed by variable dose maintenance infusion. The European Milrinone Multicentre Trial Group.
    Feneck RO
    J Cardiothorac Vasc Anesth; 1992 Oct; 6(5):554-62. PubMed ID: 1421066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation.
    Simonton CA; Chatterjee K; Cody RJ; Kubo SH; Leonard D; Daly P; Rutman H
    J Am Coll Cardiol; 1985 Aug; 6(2):453-9. PubMed ID: 4019930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologic assessment of milrinone therapy in severe heart failure patients.
    Dubois-Randé JL; Duval-Moulin AM; Saal JP; Merlet P; Lellouche D; Deleuze P; Dupouy P; Brun P; Loisance D; Castaigne A
    J Cardiovasc Pharmacol; 1991 Jun; 17(6):941-8. PubMed ID: 1714019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure.
    Pflugfelder PW; O'Neill BJ; Ogilvie RI; Beanlands DS; Tanser PH; Tihal H; Mizgala HF; Fitchett DH; Kostuk WJ
    Can J Cardiol; 1991; 7(1):5-10. PubMed ID: 2025794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic and clinical benefits with intravenous milrinone in severe chronic heart failure: results of a multicenter study in the United States.
    Anderson JL
    Am Heart J; 1991 Jun; 121(6 Pt 2):1956-64. PubMed ID: 2035427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of milrinone in chronic congestive heart failure.
    Benotti JR; Lesko LJ; McCue JE; Alpert JS
    Am J Cardiol; 1985 Oct; 56(10):685-9. PubMed ID: 4050707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
    Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
    J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of patients with severe congestive heart failure treated with oral milrinone.
    Baim DS; Colucci WS; Monrad ES; Smith HS; Wright RF; Lanoue A; Gauthier DF; Ransil BJ; Grossman W; Braunwald E
    J Am Coll Cardiol; 1986 Mar; 7(3):661-70. PubMed ID: 3950244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter, double-blind study of intravenous milrinone for patients with acute heart failure in Japan. Japan Intravenous Milrinone Investigators.
    Seino Y; Momomura S; Takano T; Hayakawa H; Katoh K
    Crit Care Med; 1996 Sep; 24(9):1490-7. PubMed ID: 8797620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Milrinone in heart failure. Effects on exercise haemodynamics during short term treatment.
    Timmis AD; Smyth P; Jewitt DE
    Br Heart J; 1985 Jul; 54(1):42-7. PubMed ID: 4015915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Milrinone. A clinical trial in 29 dogs with moderate to severe congestive heart failure.
    Keister DM; Kittleson MD; Bonagura JD; Pipers FS; Knauer KW
    J Vet Intern Med; 1990; 4(2):79-86. PubMed ID: 2187984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of long-term therapy with milrinone and the effects of milrinone withdrawal.
    Monrad ES; Baim DS; Smith HS; Lanoue AS; Silverman KJ; Gervino EV; Grossman W
    Circulation; 1986 Mar; 73(3 Pt 2):III205-12. PubMed ID: 3510776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.